Furthermore, blocking the ATM-dependent DNA damage response pathway during NK cell activation led to enhanced NK cell activity, downregulation of KLRG1, improved persistence, and better tumor clearance in a murine B cell lymphoma model [172]. The gene discussed is ATM; the disease is neoplasm.